Healthcare

Global Whooping Cough Treatment Market

March 31, 2022
ID: SR/HC-205
Format:Pdf
Pages:220

Global Whooping Cough Treatment Market by Patient Type (Pediatric, Adolescents, Adults, and Others), By Drug Type (Antibiotics, Cough syrups, Allergy Suppressants, and Others), By End-User (Hospitals, Pediatric Clinics, Online Pharmacy, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, and The Middle East & Africa)-Global Forecast to 2028

Description

Whooping Cough Treatment Market Overview

The global Whooping Cough Treatment market was expected to grow at a compound annual growth rate (CAGR) of 6.37% from 2022 to 2028. Pertussis, sometimes known as whooping cough, is a serious respiratory virus that affects children. The market’s growth is linked to the rising global prevalence of whooping cough. The expanding pediatric population is expected to promote market growth, as the illness is more severe in youngsters. Furthermore, rising public health awareness and the adoption of advanced treatment methods are expected to drive market expansion.

Moreover, growing pollution levels and high occurrences of various lung and throat illnesses, such as pharyngitis and pneumonia, are important drivers supporting the market’s growth. In addition, the majority of the share can be linked to the region’s high disease burden. The primary factors boosting the market in this region are an increase in cough cases and an increase in the number of children, which is predicted to grow over the forecasted period by 2022-2028.

What is Whooping Cough Treatment?

Pertussis, widely known as whooping cough, is a highly contagious respiratory disease. Bordetella pertussis is the bacteria that causes it. Whooping cough causes mild coughing, sneezing, runny nose, and a low fever. The dry, annoying cough transforms into coughing spells after 1 to 2 weeks. The youngster may make the characteristic whooping sound when breathing in or vomiting at the end of a spell. Whooping cough can be very serious at times, requiring hospitalization. Whooping cough puts babies at the greatest risk of catastrophic problems.

Growth Drivers

Increasing Retail Pharmacy

Retail pharmacy is growing significantly due to its widespread availability and accessibility. MedPlus, for instance, has around 1650 outlets, with 1,350 of them being self-owned and the remainder being franchised. Consumers choose these distribution methods because retailers give discounts on bulk purchases, provide speedy delivery, and have enough product stock. Furthermore, online pharmacy is expected to be the significant market growth over the forecast period. The convenience of having medications delivered to your home is a big benefit of using an online pharmacy. The low prices offered by online pharmacies are also a driving force behind the market’s growth. Moreover, During the forecast period, the rising incidence of whooping cough treatment, which necessitates medication, is expected further to drive the growth of the pharmacy retail market.

Rising population

Whooping cough symptoms range from a low fever, runny nose, and cough to breathing difficulties, whooping, and pneumonia. Because the illness is more severe in children, the market is expected to rise as the pediatric population grows. From 1 billion in 1800 to 7.9 billion in 2020, the world’s population has increased dramatically. According to the United Nations, the population will reach 8.6 billion by mid-2030, 9.8 billion by mid-2050, and 11.2 billion by 2100 globally. Additionally, 61% of the world’s population (4.7 billion) lives in Asia, 17% in Africa (1.3 billion), 10% in Europe (750 million), 8% in Latin America and the Caribbean (650 million), and the remaining 5% in Northern America (370 million) and Oceania (43 million). Therefore, the growing global population is estimated to drive the global market over the forecasted period by 2028.

Pre Covid-19 Impact on Global Whooping Cough Treatment Market

Before the pandemic, the market is expected to increase moderately, owing to factors such as the humid climate, unhealthy lifestyles, and rising disease rates. Collaborations between global organizations and governments from various countries to promote the supply of vital medications and medical supplies are also propelling market expansion.

Covid-19 Impact on Global Whooping Cough Treatment Market

COVID-19 is forecasted to negatively influence the industry’s growth during the projection period due to labor shortages and resource constraints. Furthermore, when government laws regulating lockdowns became more restrictive, the market’s growth slowed. Moreover, it is necessary to develop fresh items that will aid in the fight against the COVID-19 virus. Cough treatments are predicted to rise rapidly throughout the forecast period because of an increase in research activities aimed at developing novel medicines to treat cough produced by the virus.

Post Covid-19 Impact on Global Whooping Cough Treatment Market

Antibiotic resistance infections are projected to rise due to antibiotic abuse or overuse, causing prescription patterns to move to innovative antibiotic therapies to treat bacterial infections. While multinational pharmaceutical companies invest massive amounts of money in creating targeted therapies and treatments, contract development and manufacturing organizations (CDMOs) are looking for ways to increase the production of treatment medications and vaccines. Thus, the market is estimated to have a significant impact post-Covid-19.

By Patient Type Analysis

Based on the patient type, the market is categorized as Pediatrics, Adolescents, Adults, and Others. The Pediatric type is expected to hold a significant share of the global Whooping Cough Treatment market over the forecast period Patients who are 21 years old or younger at the time of diagnosis or treatment are referred to as pediatric patients. Because of the high prevalence and severity of whooping cough among children, the pediatric segment is expected to hold a significant proportion of the worldwide whooping cough treatment market over the forecast period. In most cases, whooping cough leads to pneumonia, a leading cause of death in children.

By Drugs Type Analysis

The market is classified as Antibiotics, Cough syrups, Allergy Suppressants, and Others. The Antibiotics drugs are estimated to have a significant share in the global Whooping Cough Treatment market over the forecasted period by 2028. Antibiotics are antimicrobial substances that are effective against microorganisms. Antibiotic drugs are widely utilized to treat and prevent bacterial infections since they are the most common form of antibacterial agent. Bacteria may be killed or inhibited by these substances. Because of the rising prevalence of infectious diseases, the need for antibiotics is skyrocketing. Collaborations for antibiotic development are expected to develop a large number of antibiotic medications in the forecasted period.

By Region Segment Analysis

The market is bifurcated into North America, Europe, Asia-Pacific, South America, and The Middle East & Africa. North America is likely to have a dominant share of the global Whooping Cough Treatment market over the forecasted period of 2022-2028. Due to an increase in the burden of COVID-19, advanced health care infrastructure, and rising prevalence of chronic obstructive pulmonary disease, flu diseases, whooping cough, and other respiratory infections, North America is expected to dominate the global whooping cough treatment market during the forecast period. These marketplaces are heavily regulated, and the healthcare infrastructure is well-developed. The rising frequency of whooping cough infections and the government’s increasing healthcare spending are key factors driving the North American market.

Competitors Analysis

The Companies include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthcare GmbH, Baxter International, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Novartis AG, and Other Prominent Players in the Whooping Cough Treatment Market.

Key Stakeholders

Market research and consulting firms
Industry Associations
Local Governments
Regulatory bodies
Whooping Cough Treatment Market providers
Suppliers
Retailers
Service Providers

Recent Developments

In May 2021, Teva Pharmaceutical Industries Ltd. announced the launch of its new Erythromycin tablets to treat or overcome a variety of bacterial infections.
In February 2020, GlaxoSmithKline plc (GSK) and Innoviva, Inc. announced the European Medicines Agency (EMA) approval of Trelegy Ellipta to treat asthma in adults.

Scope of the Report

Report Attribute	Details
Market Size Value in 2021	USD XX Billion
The revenue forecast in 2028	USD XX Billion
Growth Rate	CAGR of 6.37% from 2022 to 2028.
Historical data	2017 – 2020
Base Year	2021
Forecast period	2022 – 2028
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	The Companies include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthcare GmbH, Baxter International, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Novartis AG, and Other Prominent Players in the Whooping Cough Treatment Market.

Market Modelling

By Patient Type

Pediatric
Adolescents
Adults
Others

By Drug Type

Antibiotics
Cough syrups
Allergy Suppressants
Others

By End-User

Hospitals
Pediatric Clinics
Online Pharmacy
Others

By Region

North America
Europe
Asia-Pacific
South America
The Middle East & Africa

Table Of Contents

Methodology

Request Sample

Frequently Asked Questions (FAQ):

What is the Whooping Cough Treatment Market?

What is the growth rate of the global Whooping Cough Treatment Market?

The global Whooping Cough Treatment Market was expected to grow at a compound annual growth rate (CAGR) of 6.37% from 2022 to 2028.

What are the growth elements of the global Whooping Cough Treatment Market?

The market’s growth is linked to the rising global prevalence of whooping cough. The expanding pediatric population is expected to promote market growth, as the illness is more severe in youngsters.

Which region is expected to have the largest share in the global Whooping Cough Treatment Market?

North America is expected to have the largest share in the global Whooping Cough Treatment Market.

Who are the major players in the global Whooping Cough Treatment Market?

Select License

We Accept

Analyst support

After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.

Customer satisfaction

According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.

Inimitable expertise

Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.

Assured quality

We have created a systematic way to determine standards and satisfy your expectations.

Instant delivery

Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.

Privacy policy

We understand the inkling of your privacy, we will never misuse your email address.

Custom research service

We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.

Quality & accuracy

We provide you with the accurate quality of the customized study of an exclusive report according to your research need.

Data visualization

As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.

Information security

We truly respect your privacy and promise to keep your personal and confidential information safe and secure.